Related Experiment Video
Updated: Jul 10, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
FOXO1 is a master regulator of CAR T memory programming
Alexander Doan1, Katherine P Mueller2,3,4,5,6, Andy Chen7,8,9
1Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
The transcription factor FOXO1 promotes memory programs and prevents exhaustion in CAR T cells, enhancing their persistence and anti-tumor activity. This discovery offers a new strategy for improving CAR T cell therapies.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- CAR T cell therapy persistence is limited, hindering treatment for B cell malignancies and solid tumors.
- Memory gene expression, like TCF7 (TCF1), is crucial for CAR T cell response and long-term persistence.
- Understanding the regulators of CAR T cell memory and exhaustion is critical for enhancing therapeutic efficacy.
Conclusions:
- FOXO1 acts as a key pioneer transcription factor that promotes memory programs and restrains exhaustion in human CAR T cells.
- FOXO1-mediated memory reprogramming can significantly enhance the persistence and potency of CAR T cells for cancer immunotherapy.
- Targeting pioneer factors like FOXO1 represents a promising strategy for optimizing therapeutic T cell states and improving clinical outcomes.
Related Concept Videos
Master Transcription Regulators
Regulation of Hematopoietic Stem Cells
Lineage Commitment
Somatic to iPS Cell Reprogramming
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Regulation of Expression at Multiple Steps

